02 Apr 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019774
31 Aug 2023
// Nick Paul Taylor FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/genexines-weekly-growth-hormone-equal-novo-shot-phase-3-teeing-filing-china
21 Mar 2023
// Beth Snyder Bulik ENDPTS
https://endpts.com/novo-nordisk-remains-under-uk-scrutiny-as-mhra-conducts-its-own-review-in-incredibly-rare-case/
25 Jan 2022
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021426
27 Sep 2021
// Nick Paul Taylor FIERCEBIOTECH
https://www.fiercebiotech.com/biotech/pfizer-stumbles-close-to-finish-line-growth-hormone-race-extending-lead-rival-ascendis
22 Oct 2019
// John Carroll ENDPTS
https://endpts.com/pfizer-gets-some-encouraging-phiii-news-on-a-franchise-savior-but-is-a-dosing-advantage-worth-the-295m-upfront/
LOOKING FOR A SUPPLIER?